News

New Initiative: Drug Repurposing Venture Challenge Launches

Today marks the exciting launch of a new collaboration between ZonMw and FAST: The Drug Repurposing Venture Challenge. This innovative program challenges researchers to transform scientific breakthroughs in drug repurposing into robust plans, ready for market entry and patient benefit—all within three months. Deadline for team registration: May 20, 2025.
Drug Repurposing Venture Challenge

TargED Biopharmaceuticals’ TGD001 receives Orphan Drug Designation in the United States of America

TargED Biopharmaceuticals B.V., a clinical-stage private biotechnology company focused on developing improved treatments for thrombotic diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product TGD001, a von Willebrand factor targeted thrombolytic, for the treatment of thrombotic thrombocytopenic purpura (TTP).
TargED

Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across the United States and Germany

​​​​​​​Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the innovator of Surgical Marker Navigation and Mammotome, a globally recognized leader in breast care, are proud to announce an exclusive distribution agreement for the United States and Germany. This collaboration combines the extensive breast care knowledge and commercial capabilities of Mammotome with Sirius Medical’s technology and innovation. 
Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across the United States and Germany

The Netherlands meets Minnesota in Medtech

Are you a startup, scale-up or SME active in the medical technology sector? Do you develop medical end products or technologies? Do you have ambitions to enter the American market or grow further there?
The Netherlands meets Minnesota in Medtech

New Application Round for Biotech Booster Starting March 1

Starting March 1, 2025, knowledge institutions and partnerships can apply for funding via Biotech Booster.

LUMO Labs and Graduate Entrepreneur invest in Dutch startup Surgical Reality for advanced 3D technology for surgeons

Eindhoven, February 13, 2025 – Surgical Reality, a medical imaging startup focused on developing and commercializing surgical imaging technology, today announced receiving investment from LUMO Labs Graduate Entrepreneur and Horizon Flevolan

Praxa Sense announces international collaboration with Withings and CSEM under granted Eurostars grant

Praxa Sense is proud to announce that it has received a Eurostars grant to support a three-year collaboration with Withings, a leader in connected health devices, and CSEM, a Swiss innovation center.
Praxa Sense announces international collaboration with Withings and CSEM under granted Eurostars grant

Sirius Medical raises growth funding for expansion and development

As World Cancer Day is observed, Dutch medical device company Sirius Medical, the leader in surgical marker navigation, announced securing 10M€ in additional scale-up funding. This investment round was led by Invest-NL and Nextgen Ventures, with support from De Groot Family Office and existing investors Brabant Development Agency (BOM), Holland Capital, Curie Capital, Team Holmium, and Sirius Medical’s team.
Sirius Medical raises growth funding for expansion and development

Sirius Medical raises growth funding for expansion and development

As World Cancer Day is observed, Dutch medical device company Sirius Medical, the leader in surgical marker navigation, announced securing 10M€ in additional scale-up funding. This investment round was led by Invest-NL and Nextgen Ventures, with support from De Groot Family Office and existing investors Brabant Development Agency (BOM), Holland Capital, Curie Capital, Team Holmium, and Sirius Medical’s team.
Sirius Medical raises growth funding for expansion and development

Orgonex becomes part of Demcon group

Venture Challenge alumnus Orgonex, Spin-off from Utrecht University who is bringing an innovative bioreactor to market, found in Demcon, a high-tech developer of innovative technologies, the strong and
Orgonex